Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px

Organisation › Details

Forty51 Ventures Fund I SCSp, FIAR

https://www.forty51ventures.com

	Start	2022-07-18 closing, first
	Group	Forty51 Ventures (Group)
	Industry	Forty51 Ventures Fund I SCSp, FIAR
	Industry 2	BIOTECH

	Region	Luxembourg (cl=5)
	Country	Luxembourg
	City	n. a. Luxembourg
		Address record changed: 2023-02-13

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	43,000,000 (fund size at first closing (2022) 2022-07-18)


		Record changed: 2024-02-12

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Forty51 Ventures (Group)

[1] Mysthera Therapeutics AG. (8/21/23). "Press Release: Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies". Basel....
[2] Forty51 Ventures. (7/18/22). "Press Release: Forty51 Ventures Announces the First Close of Fund I and its First Investment". Luxembourg & Basel....
[3] Mosanna Therapeutics AG. (7/13/22). "Press Release: Mosanna Therapeutics Announces a Seed Financing Round to Advance Development of MOS-118 to Treat Metabolic Obstructive Sleep Apnea". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]